Metal-on-metal total hip arthroplasty: five- to 11-year follow-up.
|Abstract:||Metal-on-metal (MoM) total hip arthroplasty (THA) has been introduced in an attempt to reduce the wear rate and the consequent osteolysis around implants. The aim of this study was to present the intermediate to long-term clinical and radiological outcomes and to investigate the metal ion levels in the blood of patients who had undergone primary uncemented MoM THA in our institution. Between July 1997 and November 2003, 166 patients (193 hips), with a mean age of 50 years (range, 18-65 years), underwent primary MoM THA. Clinical data, radiographs, and blood samples were obtained at regular follow-up visits. Cobalt (Co), chromium (Cr), and molybdenum (Mo) ions were measured by inductively coupled plasma-mass spectrometry (ICP-MS) from the patient's whole blood. All patients were prospectively followed for a minimum of 5 years (mean, 7 years; range, 5-11 years). The mean Harris hip score (HHS) and the University of California at Los Angeles (UCLA) activity score at the latest follow-up was 88 [+ or -] 11 and 7 [+ or -] 1.8 points, respectively. Thirteen hips have been revised. Ten acetabular components had early failure, due to factory manufacturing problems. All other implants have been found stable, with no signs of aseptic loosening. The probability of survival at 11 years, if the hips that were revised due to manufacturing problems were excluded, was 98.4%. The Co and Cr metal ion levels, after increasing significantly during the first 4 to 5 years post-surgery, remained stable, with a tendency to decrease thereafter, but not significantly. During the same follow-up period, Mo ion levels remained stable. In this 5-to-11 year follow-up study of MoM THA patients, excellent survivorship, with low complications rates, was found. Results of longer follow-up studies are necessary to clarify the possible long-term effects of metal ion release.|
|Article Type:||Clinical report|
Nikolaou, Vassilios S.
Huk, Olga L.
Zukor, David J.
|Publication:||Name: Bulletin of the NYU Hospital for Joint Diseases Publisher: J. Michael Ryan Publishing Co. Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2011 J. Michael Ryan Publishing Co. ISSN: 1936-9719|
|Issue:||Date: Jan, 2011 Source Volume: 69 Source Issue: 1|
|Product:||Product Code: 3339660 Cobalt; 8000200 Medical Research; 9105220 Health Research Programs; 8000240 Epilepsy & Muscle Disease R&D NAICS Code: 331419 Primary Smelting and Refining of Nonferrous Metal (except Copper and Aluminum); 54171 Research and Development in the Physical, Engineering, and Life Sciences; 92312 Administration of Public Health Programs SIC Code: 3339 Primary nonferrous metals, not elsewhere classified|
Metal-on-metal (MoM) total hip arthroplasty (THA) was introduced in
an attempt to reduce the wear rate (1) and the consequent osteolysis
around implants which has been a well-recognized complication of
conventional metal-on-polyethylene THAs. (2,3) The first generation of
resurfacing implants was introduced in 1938 with the Wiles prosthesis
but became more common with the Ring and McKee-Farar prostheses, both
made from cobalt-chromium (Co-Cr) alloy later during the early 1960s.
(4) These early designs of MoM THAs failed, mainly due to imprecise
tolerances between the femoral head and acetabular component, resulting
in high frictional forces and early loosening. (4)
In 1988, Weber re-introduced MoM articulations in THA with the Metasul[R] (Sulzer, Basel, Switzerland) prosthesis. (5) This second generation prosthesis had improved manufacturing technology and better clearances, as well as improved metal hardness. Since then, short- and mid-term clinical results of modern MoM THAs have been promising, especially in young, active patients. (6-9) Studies have shown that MoM bearings produce 20- to 200-times less wear than conventional metal-on-polyethylene bearings. (10) However, due to the increased metal ion levels in serum, plasma, or erythrocytes of patients with MoM THA, (11-19) concerns have been raised regarding the long-term use of these prostheses. Hypersensitivity reactions (20-22) and formation of pseudotumors, (23) as well as the risk of carcinogenicity (24-25) or fetal exposure to metal ion levels in pregnant females, (26) are all concerns with these devices. The aim of the current study was to present the intermediate and long-term clinical and radiological outcomes and to investigate the metal ion levels in the blood of patients who had undergone primary uncemented MoM THA at our institution.
Materials and Methods
Between July 1997 and November 2003, 166 patients (193 hips), with a mean age of 50 years (range, 18-65 years), underwent a primary MoM THA at our institution by one of three experienced hip surgeons. Patients who had a previous infection, the presence of any other metal hardware, a known metal allergy, a renal insufficiency, or a severe medical disability that limited their ability to walk were excluded from the study. Table 1 summarizes the baseline demographics of the study group as well as the diagnosis for the surgeries. Approval by our institutional review board (IRB) was obtained, and all patients signed the approved consent forms for the use of their blood and clinical data. The characteristics of implants are summarized in Table 2.
Two validated outcome measures, the Harris hip (HHS) score (27) and the University of California at Los Angeles (UCLA) activity score, (28) were obtained at each postoperative visit. The HHS score was also obtained in all patients pre-operatively.
Anteroposterior and lateral radiographs of the pelvis were taken at each postoperative visit and at the latest follow-up; the films were analyzed at that time for implant position and signs of loosening. Vertical inclination of the acetabular component was quantified by the angle formed between a line passing through the teardrop signs and a second line representing the acetabular component's greatest diameter. Radiolucent lines and osteolysis around the femoral stem were measured according to the zones described by Gruen and colleagues. (29) Acetabular radiolucent lines were measured with use of the zones described by DeLee and Charnley. (30)
Cobalt (Co), chromium (Cr), and molybdenum (Mo) ions were measured by inductively coupled plasma-mass spectrometry (ICP-MS) in the whole blood of patients, as previously described. (21) We compared median metal ion levels in the blood of patients with the acetabular component positioned outside the "safe zone" (anteversion of 15[degrees] [+ or -] 10[degrees] and a lateral opening of 40[degrees] [+ or -] 10[degrees]) (31) to the levels in patients within this "safe zone." Overall, we identified 19 hips in 19 patients with components outside this "safe zone." There were no significant differences in age, follow-up time, and outcome scores for patients within or outside the "safe zone" (Table 3).
Normally distributed data (age, follow-up, HHS, UCLA, acetabular orientation) were analyzed with t-tests, while nonparametric data (metal ions) were analyzed with the Mann-Whitney U test and then expressed as medians. Implant survival probabilities were computed using Kaplan-Meier analysis, counting revision of one or both components, for any reason, as the terminating event and censoring patients at the time of their death or at the end of the follow-up period. The GraphPad Prism 4 software (La Jolla, California)was used for all calculations.
At the time of database closure (January 2009), 13 hips had been revised. All other patients were prospectively followed for a minimum of 5 years (mean, 7 years; range, 5-11 years).
[FIGURE 1 OMITTED]
The mean pre-operative HSS score was 39 [+ or -] 10 points, which reached 88 [+ or -] 11 points at the latest follow-up. Figure 1 shows the evolution of the HSS scores throughout the study period: no significant differences were observed at the different follow-up visits. The mean UCLA activity score was 7 [+ or -] 2 points at the first postoperative visit (2 years) and also 7 [+ or -] 2 at the latest visit (p > 0.05). Figure 2 shows the evolution of the UCLA activity scores throughout the study period. As observed for HHS, no significant differences were observed at the different follow-up times (p > 0.05).
Apart from the 13 hips that were revised, all other implants have been found stable, with no signs of aseptic loosening. The mean postoperative acetabular inclination was 40.1 [+ or -] 7.5[degrees], while the mean inclination at the latest follow-up reached 40.7[degrees] [+ or -] 6.4[degrees] (p = 0.55). The mean postoperative acetabular version was 16.8[degrees] [+ or -] 8.7[degrees], while it reached 18.3[degrees] [+ or -] 9.5[degrees] at the latest follow-up (p = 0.39). Overall, 19 hips were found to be outside the "safe zone" of 40[degrees] [+ or -] 10[degrees] of inclination and 15[degrees] [+ or -] 10[degrees] of version, as defined by Lewinnick and coworkers. (31) Non-progressive radiolucent lines greater than or equal to 2 millimeters around the femoral stem were found in four hips. In six hips, radiolucent lines greater than or equal to 2 millimeters were found. None of the femoral or acetabular implants were observed to be loose.
In order to rule out bias, we excluded patients with bilateral THAs, which left 132 hips to analyze. Figure 3 shows the levels of metal ions in the whole blood of patients during the study period. After increasing significantly during the first 4 to 5 years post-surgery (p < 0.0001), Co (Fig. 3A) and Cr (Fig. 3B) levels tended to decrease, but not significantly thereafter, in comparison with the levels observed at 4 to 5 years (p = 0.06 and p = 0.11 for Co and Cr, respectively). Cobalt levels passed from 2.16, 2.94, 2.33, and 2.30 [micro]g/L in 1 to 3 years, 4 to 5 years, 6 to 7 years, and more than 7 years groups, respectively (Fig. 3A). Cr levels passed from 0.35, 0.74, 0.70, and 0.40 [micro]g/L in the 1 to 3 years, 4 to 5 years, 6 to 7 years, and more than 7 years groups, respectively (Fig. 3B). During the same follow-up period Mo ion levels remained stable between 1.46 [micro]g/L (6 to 7 years) and 1.70 [micro]g/L (1 to 3 years).
[FIGURE 2 OMITTED]
[FIGURE 3 OMITTED]
[FIGURE 4 OMITTED]
Effect of Acetabular Orientation on Metal Ion Levels
Results showed that in patients with acetabular components positioned outside the "safe zone," the levels of Co (2.93 [micro]g/L) and Cr (1.34 [micro]g/L) ions at the last visit were significantly higher (p = 0.018 and p = 0.020, respectively) than levels of Co (2.00 [micro]g/L) and Cr (0.683 [micro]g/L) in the blood of patients whose components were inside the "safe zone" (Fig. 4). There were no differences in the levels of Mo (p = 0.79) (Table 3).
From the 13 hips that have been revised (Table 4), 10 had an early failure, due to early loosening of the acetabular component. All of these patients had an uncemented Sulzer Interop[TM] acetabular component implanted. This implant was recalled by the company in December 2001, after several surgeons reported cases of early failure. The cause of this complication is believed to be a failure of bony in-growth, due to a residue of machining oil left on the backside of the component at the time of manufacturing. One other hip developed an early infection and was treated with washout and liner exchange. One additional acetabular component had been revised the same day, due to intra-operative poor technique. One hip has been revised because of aseptic loosening of an under-sized femoral component (natural hip).
Overall, the revision rate was 6.7%. If we exclude the hips that have been revised due to the manufacturing problems of the acetabular component, the revision rate was as low as 1.55%. With "revision for any reason" as the end point, survival at 11 years was 93.8%. If we exclude the hips that were revised due to manufacturing problems of the acetabular component, then survival was 98.4% (Fig. 5).
The results of the present study show that, at the intermediate follow-up time of 5 to 11 years, uncemented MoM THAs performed well, with a survivorship at 11 years of 98.4%. Additionally, the radiographic analysis of the THAs did not reveal any progressive signs of loosening in any of the implanted prostheses. The outcome for patients with this second generation of MoM THA appears better than what was reported for the first generation of MoM prostheses.
[FIGURE 5 OMITTED]
The long-term results of the second generation of MoM THAs reported in the literature have shown excellent outcomes. Grubl and associates (7) analyzed results from 105 cementless primary MoM THAs and reported an overall survival of 98.6% at 10 years. In another study, Neumann and colleagues (32) reported at a mean follow-up of 10.5 years 98% survivorship of the stem and 96% for the cup. At mid-term (4 to 7 years), Dorr and coworkers (33) reported a survival rate of 98.2% on 70 MoM THAs. Kim and associates (9) reviewed the results of a series of active patients who were less than 50 years old when they underwent cementless THA with the use of the Metasul[R] MoM articulation. They found that, at a mean 7-year follow-up, only one out of the 70 THAs had been revised for liner exchange due to focal pelvic osteolysis.
In our series, a total of 13 hips (out of 193) have been revised at the time of database closure. Ten hips had early revision due to aseptic loosening. These prostheses were parts of the Sulzer Interop[TM] acetabular component, recalled by the company in December 2001, after several surgeons reported cases of early failure. A residue of machining oil that was left at the backside of the component at the time of manufacturing is believed to be the cause of early loosening. (34) As a result, inflammation at the bone-implant interface led to failure of bone in-growth. Patients experienced groin pain and early acetabulum loosening. If we exclude revisions due to this cause, only three hips have been revised during 5- to 11-year follow-up, resulting in a survivorship of 98.4% at 11 years. These results confirm the results obtained by other groups with second generation MoM THAs.
One of the main concerns that has been raised about the use of MoM THA involves the elevation of the metal ion levels in the blood and urine of patients with these bearings. The increase of Co and Cr levels is a well-proven fact in patients with the first generation of MoM THAs, as a result of wear of the implants. For example, Sauve and colleagues (19) analyzed metal ion levels in patients who had primary, well-fixed, Ring MoM THAs for more than 30 years. They found that Co and Cr ion levels were elevated by five- and three-times, respectively, compared with those in their reference groups. In another study, Jacobs and coworkers (35) found a nine-fold elevation in serum Cr and three-fold elevation in serum Co concentrations in patients with long-term use (more than 20 years) of McKee-Farrar hip arthroplasties, as compared to controls.
There is relative paucity of evidence regarding the long-term metal ion release in patients with second generation MoM THAs. In a recent study, Grubl and associates (7) reported metal ion concentration in the serum of 22 patients with unilateral MoM THA after a minimum 10-year follow-up. They found that the median serum Co concentration was 0.75 [micro]g/L (range, 0.3-50.1 [micro]g/L), and the median serum Cr level was 0.95 [micro]g/L (range, 0.3-58.6 [micro]g/L). However, the investigators only measured metal ion levels at a single point in time. In another study, Lazennec and colleagues (14) investigated metal ion levels in patients with unilateral MoM-backed polyethylene cemented hip arthroplasties with 28-mm femoral heads. They reported stable serum Co over time (1.3 to 1.7 [micro]g/L up to 9 years post-surgery) and a tendency for decreased levels of Cr from 2.18 [micro]g/L at 1 year to 1.49 [micro]g/L at 9 years. These studies are in agreement with the present study, showing a rapid increase of both Co and Cr ions, followed by a tendency to decrease thereafter.
Extensive acetabular inclination or version has been linked with high rates of polyethylene wear in cases of metal-on-polyethylene THAs (36) and also with high metal ion release in cases of metal-on-metal hip resurfacing. (18,37) Also, the extreme anteversion (or inadequate anteversion) angles have been associated with a rise in metal ion levels in hip resurfacing. (38-39) In their study, Brodner and coworkers (40) investigated the correlation between cup inclination and serum Co or Cr concentrations in patients with MoM THAs. They found no statistically significant differences in ion levels in the three groups of patients with different acetabular component inclination. However, there were three patients with cup inclination angles of more than 55[degrees] who exhibited 9.8- to 53.6-fold elevated Co and 9.5- to 30.5-fold elevated Cr levels when compared to the median concentrations of their trial. Our study showed that patients with acetabular orientations outside the "safe zone" of 40[degrees] [+ or -] 10[degrees] of inclination and 15[degrees] [+ or -] 10[degrees] of version, as defined by Lewinnick and associates, (31) had significantly higher levels of Co and Cr ions at the last visit than levels of Co and Cr in the blood of patients within the "safe zone." Also, outlier values were mainly found in this group of patients, suggesting that positioning the acetabular component in the "safe zone" is important towards the attempt of reducing metal ion levels in patients with MoM THA.
A limitation in our study is the absence of pre-operative Co and Cr level values for our group of patients: we cannot therefore precisely analyze the extent of increase after the surgery. Also, we did not document clinical findings related to malignancies, renal failures, or other pathologies that could be linked with metal ion release from the MoM articulations. However, in our study group, we did not observe any hypersensitivity reaction or pseudotumor formation that could lead to THA failure and revision.
The present 5- to 11-year follow-up study of patients with MoM THA demonstrated excellent survivorship, with low complication rates. After an early increase during the first 4 to 5 years, metal ion levels in patients' blood remained stable, with a tendency to decrease. Results of longer follow-up studies are necessary to further confirm our findings and clarify the possible long-term effects of metal ion release in patients' circulation.
The authors wish to thank Maricar Alminia and Laura Desrosiers for their help in the administration of the questionnaires, recording the clinical data, and collecting the blood samples.
None of the authors have a financial or proprietary interest in the subject matter or materials discussed, including, but not limited to, employment, consultancies, stock ownership, honoraria, and paid expert testimony.
(1.) McKellop H, Park SH, Chiesa R, et al. In vivo wear of three types of metal on metal hip prostheses during two decades of use. Clin Orthop Relat Res. 1996; (329 Suppl): S128-40.
(2.) Oparaugo PC, Clarke IC, Malchau H, Herberts P. Correlation of wear debris-induced osteolysis and revision with volumetric wear-rates of polyethylene: a survey of 8 reports in the literature. Acta Orthop Scand. 2001; 72(1): 22-8.
(3.) Wroblewski BM. Osteolysis due to particle wear debris following total hip arthroplasty: the role of high-density polyethylene. Instr Course Lect. 1994; 43: 289-94.
(4.) Cuckler JM. The rationale for metal-on-metal total hip arthroplasty. Clin Orthop Relat Res. 2005; 441: 132-6.
(5.) Weber BG. Experience with the Metasul total hip bearing system. Clin Orthop Relat Res. 1996; (329 Suppl): S69-77.
(6.) Delaunay CP, Bonnomet F, Clavert P, et al. THA using metal-on-metal articulation in active patients younger than 50 years. Clin Orthop Relat Res. 2008; 466(2): 340-6.
(7.) Grubl A, Marker M, Brodner W, et al. Long-term follow-up of metal-on-metal total hip replacement. J Orthop Res. 2007; 25(7): 841-8.
(8.) Migaud H, Jobin A, Chantelot C, et al. Cementless metal-on-metal hip arthroplasty in patients less than 50 years of age: comparison with a matched control group using ceramic-on-polyethylene after a minimum 5-year follow-up. J Arthroplasty. 2004; 19; (8 Suppl 3): 23-8.
(9.) Kim SY, Kyung HS, Ihn JC, et al. Cementless Metasul metal-on-metal total hip arthroplasty in patients less than fifty years old. J Bone Joint Surg Am. 2004; 86(11): 2475-81.
(10.) Silva M, Heisel C, Schmalzried TP. Metal-on-metal total hip replacement. Clin Orthop Relat Res. 2005; 430: 53-61.
(11.) Jacobs JJ, Hallab NJ, Skipor AK, Urban RM. Metal degradation products: a cause for concern in metal-metal bearings? Clin Orthop Relat Res. 2003; 417: 139-47.
(12.) Savarino L, Granchi D, Ciapetti G, et al. Ion release in patients with metal-on-metal hip bearings in total joint replacement: a comparison with metal-on-polyethylene bearings. J Biomed Mater Res. 2002; 63(5): 467-74.
(13.) Vendittoli PA, Amzica T, Roy AG, et al. Metal ion release with large-diameter metal-on-metal hip arthroplasty. J Arthroplasty. 2011 Feb; 26(2): 282-8; Epub 2010 Mar 4.
(14.) Lazennec JY, Boyer P, Poupon J, et al. Outcome and serum ion determination up to 11 years after implantation of a cemented metal-on-metal hip prosthesis. Acta Orthop. 2009; 80(2) :168-73.
(15.) Daniel J, Ziaee H, Pradhan C, McMinn DJ. Six-year results of a prospective study of metal ion levels in young patients with metal-on-metal hip resurfacings. J Bone Joint Surg Br. 2009; 91(2): 176-9.
(16.) De Smet K, De Haan R, Calistri A, et al. Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am. 2008; (90 Suppl 4): 202-8.
(17.) Engh CA Jr, MacDonald SJ, Sritulanondha S, et al. 2008 John Charnley award: metal ion levels after metal-on-metal total hip arthroplasty: a randomized trial. Clin Orthop Relat Res. 2009; 467(1): 101-11.
(18.) De Haan R, Pattyn C, Gill HS, et al. Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg Br. 2008; 90(10): 1291-7.
(19.) Sauve P, Mountney J, Khan T, et al. Metal ion levels after metal-on-metal Ring total hip replacement: a 30-year follow up study. J Bone Joint Surg Br. 2007; 89(5): 586-90.
(20.) Kwon YM, Thomas P, Summer B, et al. Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty. J Orthop Res. 2010; 28(4): 444-50.
(21.) Antoniou J, Zukor DJ, Mwale F, et al. Metal ion levels in the blood of patients after hip resurfacing: a comparison between twenty-eight and thirty-six-millimeter-head metal-on-metal prostheses. J Bone Joint Surg Am. 2008; (90 Suppl 3): 142-8.
(22.) Lachiewicz PF. Metal-on-metal hip resurfacing: a skeptic's view. Clin Orthop Relat Res. 2007; 465: 86-91.
(23.) Pandit H, Glyn-Jones S, McLardy-Smith P, et al. Pseudotumours associated with metal-on-metal hip resurfacings. J Bone Joint Surg Br. 2008; 90(7): 847-51.
(24.) Visuri T, Pukkala E, Paavolainen P, et al. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop Relat Res. 1996; (329 Suppl): S280-9.
(25.) Visuri TI, Pukkala E, Pulkkinen P, Paavolainen P. Cancer incidence and causes of death among total hip replacement patients: a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc Inst Mech Eng H. 2006; 220(2): 399-407.
(26.) Ziaee H, Daniel J, Datta AK, et al. Transplacental transfer of cobalt and chromium in patients with metal-on-metal hip arthroplasty: a controlled study. J Bone Joint Surg Br. 2007; 89(3): 301-5.
(27.) Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969; 51(4): 737-55.
(28.) Zahiri CA, Schmalzried TP, Szuszczewicz ES, Amstutz HC. Assessing activity in joint replacement patients. J Arthroplasty. 1998; 13(8): 890-5.
(29.) Gruen TA, McNeice GM, Amstutz HC. "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res. 1979; 141: 17-27.
(30.) DeLee JG, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res. 1976(121): 20-32.
(31.) Lewinnek GE, Lewis JL, Tarr R, et al. Dislocations after total hip-replacement arthroplasties. J Bone Joint Surg Am. 1978; 60(2): 217-20.
(32.) Neumann DR, Thaler C, Hitzl W, et al. Long-term results of a contemporary metal-on-metal total hip arthroplasty. A 10-year follow-up study. J Arthroplasty. 2010 Aug; 25(5): 700-8.
(33.) Dorr LD, Wan Z, Longjohn DB, et al. Total hip arthroplasty with use of the Metasul metal-on-metal articulation. Four to seven-year results. J Bone Joint Surg Am. 2000; 82(6): 789-98.
(34.) Blumenfeld TJ, Bargar WL. Early aseptic loosening of a modern acetabular component secondary to a change in manufacturing. J Arthroplasty. 2006; 21(5): 689-95.
(35.) Jacobs JJ, Skipor AK, Doorn PF, et al. Cobalt and chromium concentrations in patients with metal on metal total hip replacements. Clin Orthop Relat Res. 1996; (329 Suppl): S256-63.
(36.) Schmalzried TP, Guttmann D, Grecula M, Amstutz HC. The relationship between the design, position, and articular wear of acetabular components inserted without cement and the development of pelvic osteolysis. J Bone Joint Surg Am. 1994; 76(5): 677-88.
(37.) Hart AJ, Buddhdev P, Winship P, et al. Cup inclination angle of greater than 50 degrees increases whole blood concentrations of cobalt and chromium ions after metal-on-metal hip resurfacing. Hip Int. 2008; 18(3): 212-9.
(38.) Langton DJ, Jameson SS, Joyce TJ, et al. The effect of component size and orientation on the concentrations of metal ions after resurfacing arthroplasty of the hip. J Bone Joint Surg Br. 2008; 90(9): 1143-51.
(39.) Langton DJ, Sprowson AP, Joyce TJ, et al. Blood metal ion concentrations after hip resurfacing arthroplasty: a comparative study of articular surface replacement and Birmingham Hip Resurfacing arthroplasties. J Bone Joint Surg Br. 2009; 91(10): 1287-95.
(40.) Brodner W, Grubl A, Jankovsky R, et al. Cup inclination and serum concentration of cobalt and chromium after metal-on-metal total hip arthroplasty. J Arthroplasty. 2004;19(8 Suppl 3): 66-70.
Vassilios S. Nikolaou, M.D., Ph.D., is from the Division of Orthopaedic Surgery, McGill University, and SMBD-Jewish General Hospital, Montreal. Alain Petit, Ph.D., Olga L. Huk, M.D., M.Sc., David J. Zukor, M.D., and John Antoniou, M.D., Ph.D., are from the Division of Orthopaedic Surgery, McGill University, SMBD-Jewish General Hospital, and the Lady Davis Institute for Medical Research, Montreal. Kevin Debiparshad, M.D., is from the Lady Davis Institute for Medical Research, Montreal, Canada.
Correspondence: Vassilios S. Nikolaou, M.D., Ph.D., Suite 2014, Division of Orthopaedic Surgery, McGill University, 2021 Atwater Avenue, Montreal, Quebec H3H 2P2, Canada; vassilios.nikolaou@ gmail.com.
Table 1 Demographic Data Patients (N) 166 (89/77) (males/females) Hips (left/right) 193 (78/115) Mean age (range) 50 years (17-66) Primary diagnosis Osteoarthritis: 142 Osteonecrosis: 19 Congenital dislocation of the hip: 11 Rheumatoid arthritis: 8 Ankylosing spondylitis: 8 Other: 5 Table 2 Surgical Parameters Approach Direct lateral: 179 Posterior: 14 Femoral components Natural Hip: 158 Prodigy: 33 S-Rom: 2 Acetabular components Inter-op: 109 Pinnacle: 38 Converge: 37 Fitek: 9 Femoral head size 26 mm: 1 28 mm: 177 36 mm: 15 Mean acetabular cup 53.6 mm (48-65) size (range) Table 3 Demographic and Clinical Data of Patients Within and Outside the "Safe Zone" Within Outside P Value Number of hips 114 19 - Age 50 [+ or -] 10 49 [+ or -] 10 0.38 Mean follow-up 7.2 [+ or -] 1.6 7.7 [+ or -] 2.0 0.25 Mean HHS 89 [+ or -] 11 86 [+ or -] 16 0.87 Mean UCLA 7.0 [+ or -] 1.8 6.7 [+ or -] 1.6 0.31 HHS, Harris hip score; UCLA, University of California, Los Angeles. Table 4 Descriptive Summary of the Revisions Time to Age Revision Patient Gender (Years) Side (Months) 1 F 57 R 7.4 2 F 60 R 6.6 3 F 60 L 4.3 4 M 48 R 33.3 5 M 42 R 19.2 6 F 57 L 24.1 7 F 52 L 0 8 F 53 R 7.6 9 F 34 L 16.1 10 F 43 L 34 11 M 39 R 10.3 12 M 55 L 6 13 M 64 L 1.3 Patient Cause 1 Metasul [R] factory problem 2 Metasul [R] factory problem 3 Metasul [R] factory problem 4 Metasul [R] factory problem 5 Aseptic loosening of undersized stem (natural hip) 6 Metasul [R] factory problem 7 Intraoperative bad technique: revised same day (Metasul [R]) 8 Metasul [R] factory problem 9 Metasul [R] factory problem 10 Metasul [R] factory problem 11 Metasul [R] factory problem 12 Metasul [R] factory problem 13 Early infection: underwent exchange of liner
|Gale Copyright:||Copyright 2011 Gale, Cengage Learning. All rights reserved.|